Skip to content

Addiction: all studies

Page 506 of 860: studies 5,051 to 5,060 of 8,594, newest first. Back to the addiction overview

Research

Psilocybin and MDMA for the treatment of trauma-related psychopathology

International Review of Psychiatry April 3, 2021 Catherine Bird, Nadav L. Modlin, James J. H. Rucker 78 citations

This review examines the role of trauma in psychiatric morbidity and analogous psychoneurobiological changes. Trauma is a necessary criterion for Post-Traumatic Stress Disorder (PTSD), however, trauma history is highly correlated with a variety of psychiatric conditions. Some evidence suggests that Major Depressive Disorder (MDD) is the most common psychiatric condition that arises following...

Pain regulation during mindfulness meditation: Phenomenological fingerprints in novices and experts practitioners

European Journal of Pain April 2, 2021 Stefano Poletti, Oussama Abdoun, Jelle Zorn et al. 25 citations

BACKGROUND: The way people respond to pain is based on psychological mechanisms, beliefs and expectations. Mindfulness meditation (MM) has been shown to regulate pain and mental suffering through different mechanisms such as positive reappraisal, attentional and emotional regulation. Yet, subjective experience and meaning of pain in connection with MM are still largely unexplored. METHODS: The...

Technostalgia, Nationalism, and the Extended Mind inKrapp's Last Tape

Journal of Beckett Studies April 1, 2021 Ken Alba

This article considers how Krapp's relationships with the various cognitive apparatuses he surrounds himself with prefigures what subjectivity looks like in the information age. The subjectivity that arises out of the complex interactions between the listener and their prosthetic memory can be characterised as what Olga Beloborodova has called ‘postcognitivist’. Considering Krapp's relationship...

“I have no disease and weed just relaxes me!”: The therapeutic challenge in young patients with psychosis and cannabis abuse

European Psychiatry April 1, 2021 P. Mota

Introduction Substance use disorders (SUDs) are estimated to affect around 30 million people worldwide, and are characterized by repeated use of a substance that leads to clinically significant impairment or suffering, making it a serious health problem, with high associated costs. Objectives Understand and evaluate the impact of cannabis use on adherence to treatment in young patients with...

Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies.

Psychopharmacology April 2021 Dan L McElroy, Andrew J Roebuck, Gavin A Scott et al.

Antipsychotics help alleviate the positive symptoms associated with schizophrenia; however, their debilitating side effects have spurred the search for better treatment options. Novel compounds can be screened for antipsychotic potential in neuronal cell cultures and following acute N-methyl-D-aspartate (NMDA) receptor blockade with non-competitive antagonists such as MK-801 in rodent...

There Is More to Mindfulness Than Emotion Regulation: A Study on Brain Structural Networks

Frontiers in Psychology April 1, 2021 Sabina Baltruschat, Antonio Cándido, Antonio Maldonado et al.

Dispositional mindfulness and emotion regulation are two psychological constructs closely interrelated, and both appear to improve with the long-term practice of mindfulness meditation. These constructs appear to be related to subcortical, prefrontal, and posterior brain areas involved in emotional processing, cognitive control, self-awareness, and mind wandering. However, no studies have yet...

DOI: 10.3389/fpsyg.2021.659403 (opens in new tab) Full text (opens in new tab) Dispositional mindfulness Emotion regulation Structural networks Individual differences +2

Therapeutic use of psychedelic drugs in depression disorders

European Psychiatry April 1, 2021 M. Trigo

Introduction Depression is one of the most prevalent mental illnesses, leading to important personal distress and economic consequences. Treatment is long, often involving psychotherapy and pharmacological treatment, and relapses are frequent. Used mostly for treatment of mood disorders and alcohol dependence, drugs such as lysergic acid diethylamide (LSD) were studied in the 1950’s and showed...

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT 2A and ampa in the medial prefrontal cortex (MPFC)

European Psychiatry April 1, 2021 Athanasios Markopoulos, Antonio Inserra, Danilo de Gregorio et al. 5 citations

Introduction Autism Spectrum Disorder and Social Anxiety Disorder are mental illnesses characterized by a dysfunction in social behavior (SB); a phenomenon largely mediated by the medial prefrontal cortex (mPFC). Clinical studies have demonstrated that lysergic acid diethylamide (LSD), a partial agonist of the 5-HT 2A receptor, can promote SB. However, its mechanism of action on SB is unknown....

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD

European Psychiatry April 1, 2021 B. Van der Kolk

Introduction Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Previous research has led to the designation of 3,4-methylenedioxymethamphetamine (MDMA) as a Breakthrough Therapy for treatment of post-traumatic stress disorder (PTSD) when administered as an adjunct to psychotherapy....

Long-Term Efficacy of Combination Therapy of Transcranial Magnetic Stimulation with Ketamine for Patients with Treatment-Resistant Depression

CNS Spectrums April 1, 2021 Steve Best, Dan G. Pavel, Natalie Haustrup 1 citation

AbstractBackgroundRepetitive transcranial magnetic stimulation (rTMS) is a safe, effective and non-invasive treatment for many psychiatric illnesses, including treatment-resistant depression (TRD). Ketamine, an NMDA receptor antagonist, is also an effective antidepressant. This retrospective review examined the clinical benefits of combining these two established treatments for patients...